RxDoctor Payments Data

Zachary Roberts, MD

Colon & Rectal Surgery · Dallas, TXNPI 1487159471

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (54.1%), education and travel and lodging — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Johnson & Johnson at 55.5% of the total. Reporting peaked in 2024 at $11,912 and has fallen 56.0% since, to $5,240 in 2025.

$17,280in general payments, 2019–2025

Across 71 payments — averaging $243.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$10K
  • Intuitive Surgical$6K
  • Medical Device Business Services, Inc.$1K
  • Takeda Pharmaceuticals U.S.A., Inc.$336
  • AbbVie$164
  • Guard Medical Inc.$139
  • plus $384 from 9 others

What the payments were for

  • Consulting fees$9,34554%
  • Travel & lodging$2,65215%
  • Food & beverage$1,78410%
  • Education$3,50020%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,280 in reported general payments places this provider in the 80th percentile of 200 colon & rectal surgery providers in Texas.

See all colon & rectal surgery providers in Texas

Medicare billing

Part B allowed, 2024
$12,020
Medicare patients
18
Services billed
50

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl36$112

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →